Recurrent transcriptional responses in AML and MDS patients treated with decitabine

The molecular events responsible for decitabine responses in myelodysplastic syndrome and acute myeloid leukemia patients are poorly understood. Decitabine has a short serum half-life and limited stability in tissue culture. Therefore, theoretical pharmacologic differences may exist between patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhyay, Pawan, Beales, Jeremy, Shah, Nakul M., Gruszczynska, Agata, Miller, Christopher A., Petti, Allegra A., Ramakrishnan, Sai Mukund, Link, Daniel C., Ley, Timothy J., Welch, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833843/
https://www.ncbi.nlm.nih.gov/pubmed/35429619
http://dx.doi.org/10.1016/j.exphem.2022.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833843/
https://www.ncbi.nlm.nih.gov/pubmed/35429619
http://dx.doi.org/10.1016/j.exphem.2022.04.002

Ejemplares similares